News & Updates

Show Multimedia Only

Cannabidiol beneficial to patients with gastroparesis

28 Jul 2023

For patients with gastroparesis, the use of cannabidiol (CBD) provides symptom relief and improves the tolerance of liquid nutrient intake, despite a delay in gastric emptying of solids (GES), as shown in a study.

28 Jul 2023

Which parameters predict sacral neuromodulation outcomes?

28 Jul 2023

Some parameters that are usually assessed intraoperatively during stage 1 sacral neuromodulation appear to be of little use in predicting acute and long-term outcomes in urgency urinary incontinence, reveals a study.

28 Jul 2023

Integrated analysis supports long-term efficacy of ritlecitinib for alopecia areata

28 Jul 2023 by

An integrated analysis of the pivotal phase IIb/III ALLEGRO and phase III ALLEGRO-LT studies demonstrated the long-term efficacy of the oral JAK3/TEC family kinase inhibitor ritlecitinib for alopecia areata (AA).

28 Jul 2023

Risperidone may be easy on kidneys

28 Jul 2023

Risperidone use among patients with schizophrenia appears to confer some protection against the risk of kidney function decline, as reported in a study.

28 Jul 2023

Tranexamic acid does little to prevent hematoma expansion in patients with NOAC-ICH

27 Jul 2023

There is no evidence to suggest that treatment with tranexamic acid (TXA) helps limit hematoma expansion in patients with intracerebral haemorrhage (ICH) associated with nonvitamin K antagonist oral anticoagulants (NOACs), according to a study.

27 Jul 2023

Sexual dysfunction prevalent in adults with psychiatric disorders

27 Jul 2023

Patients with a psychiatric disorder tend to suffer from sexual dysfunction as well, with variations in the frequency and phase of reported sexual dysfunction, as shown in a systematic review.

27 Jul 2023

AKI duration tied to CKD, CVD risk

27 Jul 2023 by

The duration of acute kidney injury (AKI) was associated with the risks of chronic kidney disease (CKD) but not overall cardiovascular disease (CVD*), a population-based Danish cohort study suggests.

27 Jul 2023

Niraparib maintenance confers prolonged survival in advanced ovarian cancer

27 Jul 2023

Maintenance therapy with niraparib appears to increase progression-free survival (PFS) in patients with advanced ovarian cancer, irrespective of postoperative residual disease or biomarker status, according to data from the phase III PRIME study.

27 Jul 2023

Nemolizumab relieves itch, clears skin in patients with prurigo nodularis

27 Jul 2023 by

Treatment with nemolizumab significantly improves itch and skin clearance in patients with prurigo nodularis compared with placebo, according to the phase III OLYMPIA 2 trial presented at WCD 2023.

27 Jul 2023

Adverse birth outcomes tied to increase T2D risk high among certain postmenopausal women

26 Jul 2023

For postmenopausal women with a history of gestational diabetes, delivering high birth weight infants or hypertensive disorders of pregnancy poses a heightened risk of developing type 2 diabetes (T2D) in the future, according to a study.

26 Jul 2023

News & Updates

Showing Multidisciplinary articles

Showing

Specialty:

Cannabidiol beneficial to patients with gastroparesis

Which parameters predict sacral neuromodulation outcomes?

Integrated analysis supports long-term efficacy of ritlecitinib for alopecia areata

Risperidone may be easy on kidneys

Tranexamic acid does little to prevent hematoma expansion in patients with NOAC-ICH

Sexual dysfunction prevalent in adults with psychiatric disorders

AKI duration tied to CKD, CVD risk

Niraparib maintenance confers prolonged survival in advanced ovarian cancer

Nemolizumab relieves itch, clears skin in patients with prurigo nodularis

Adverse birth outcomes tied to increase T2D risk high among certain postmenopausal women